• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葛根素在中枢神经系统疾病中的神经保护机制:最新进展

Neuroprotective Mechanisms of Puerarin in Central Nervous System Diseases: Update.

作者信息

Yu Chao-Chao, Du Yan-Jun, Li Jin, Li Yi, Wang Li, Kong Li-Hong, Zhang Ying-Wen

机构信息

1Department of Integrated Chinese and Western Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.

2College of Acupuncture and Orthopedics, Hubei University of Chinese Medicine, Wuhan, Hubei, China.

出版信息

Aging Dis. 2022 Jul 11;13(4):1092-1105. doi: 10.14336/AD.2021.1205.

DOI:10.14336/AD.2021.1205
PMID:35855345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9286922/
Abstract

Due to global population aging and modern lifestyle changes, the incidence of central nervous system (CNS) disorders, such as neurodegenerative diseases, neuropsychiatric disorders, and cerebrovascular diseases, is increasing and has become a major public health challenge. Current medications commonly used in the clinic are far from satisfactory and may cause serious side effects. Therefore, the identification of novel drugs for the effective management of CNS diseases is very urgent. Puerarin, a highly bioactive ingredient isolated from , is known to possess a broad spectrum of pharmacological properties including anti-diabetic, anti-inflammatory, anti-antioxidant, neuroprotective, and cardioprotective features. However, its clinical application is limited due to its poor water solubility. Since puerarin has demonstrated a wide range of neuroprotective functions in various CNS diseases, such as Alzheimer's disease, Parkinson's disease, cerebral ischemia, depression, and spinal cord injury, it has been attracting increasingly intense attention worldwide. In this review, we intend to extensively summarize the research progress on neuroprotective mechanisms of puerarin in recent years and discuss the future directions of its application in CNS disease treatment.

摘要

由于全球人口老龄化和现代生活方式的改变,中枢神经系统(CNS)疾病的发病率正在上升,已成为一项重大的公共卫生挑战,这些疾病包括神经退行性疾病、神经精神疾病和脑血管疾病。目前临床上常用的药物远不能令人满意,并且可能会引起严重的副作用。因此,识别用于有效治疗中枢神经系统疾病的新型药物迫在眉睫。葛根素是从[具体来源未给出]中分离出的一种具有高生物活性的成分,已知具有广泛的药理特性,包括抗糖尿病、抗炎、抗氧化、神经保护和心脏保护作用。然而,由于其水溶性差,其临床应用受到限制。由于葛根素在各种中枢神经系统疾病(如阿尔茨海默病、帕金森病、脑缺血、抑郁症和脊髓损伤)中已显示出广泛的神经保护功能,它在全球范围内受到越来越多的关注。在这篇综述中,我们打算广泛总结近年来葛根素神经保护机制的研究进展,并讨论其在中枢神经系统疾病治疗中的应用前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6b/9286922/597bb6f20af9/AD-13-4-1092-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6b/9286922/a19c5f6a1d58/AD-13-4-1092-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6b/9286922/ed5d581cc5d4/AD-13-4-1092-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6b/9286922/74d3ae5865fa/AD-13-4-1092-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6b/9286922/8ca77438ddad/AD-13-4-1092-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6b/9286922/597bb6f20af9/AD-13-4-1092-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6b/9286922/a19c5f6a1d58/AD-13-4-1092-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6b/9286922/ed5d581cc5d4/AD-13-4-1092-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6b/9286922/74d3ae5865fa/AD-13-4-1092-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6b/9286922/8ca77438ddad/AD-13-4-1092-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6b/9286922/597bb6f20af9/AD-13-4-1092-g5.jpg

相似文献

1
Neuroprotective Mechanisms of Puerarin in Central Nervous System Diseases: Update.葛根素在中枢神经系统疾病中的神经保护机制:最新进展
Aging Dis. 2022 Jul 11;13(4):1092-1105. doi: 10.14336/AD.2021.1205.
2
Therapeutic potential of puerarin against cerebral diseases: From bench to bedside.葛根素治疗脑部疾病的潜力:从实验室到临床。
Eur J Pharmacol. 2023 Aug 15;953:175695. doi: 10.1016/j.ejphar.2023.175695. Epub 2023 Mar 26.
3
Puerarin: a review of pharmacological effects.葛根素:药理学作用综述。
Phytother Res. 2014 Jul;28(7):961-75. doi: 10.1002/ptr.5083. Epub 2013 Dec 13.
4
Puerarin: a potential natural neuroprotective agent for neurological disorders.葛根素:一种有潜力的治疗神经障碍的天然神经保护剂。
Biomed Pharmacother. 2023 Jun;162:114581. doi: 10.1016/j.biopha.2023.114581. Epub 2023 Mar 24.
5
Investigating the Potential Therapeutic Mechanisms of Puerarin in Neurological Diseases.葛根素治疗神经系统疾病的潜在作用机制研究。
Mol Neurobiol. 2024 Dec;61(12):10747-10769. doi: 10.1007/s12035-024-04222-4. Epub 2024 May 23.
6
Potential medicinal value of celastrol and its synthesized analogues for central nervous system diseases.藜芦碱及其合成类似物在中枢神经系统疾病方面的潜在药用价值。
Biomed Pharmacother. 2021 Jul;139:111551. doi: 10.1016/j.biopha.2021.111551. Epub 2021 Apr 14.
7
Puerarin: A protective drug against ischemia-reperfusion injury.葛根素:一种抗缺血再灌注损伤的保护药物。
Front Pharmacol. 2022 Aug 24;13:927611. doi: 10.3389/fphar.2022.927611. eCollection 2022.
8
Management of Diabetes Mellitus with Puerarin, a Natural Isoflavone From Pueraria lobata.葛根素,一种从野葛中提取的天然异黄酮,用于糖尿病的治疗。
Am J Chin Med. 2018;46(8):1771-1789. doi: 10.1142/S0192415X18500891. Epub 2018 Dec 10.
9
Protective effects and mechanism of puerarin targeting PI3K/Akt signal pathway on neurological diseases.葛根素靶向PI3K/Akt信号通路对神经疾病的保护作用及机制
Front Pharmacol. 2022 Oct 24;13:1022053. doi: 10.3389/fphar.2022.1022053. eCollection 2022.
10
Recent Advances in Methods of Puerarin Biotransformation.葛根素生物转化方法的最新进展
Mini Rev Med Chem. 2016;16(17):1392-1402. doi: 10.2174/1389557516666160505114456.

引用本文的文献

1
Salidroside inhibits melanin synthesis and melanoma growth via mTOR and PI3K/Akt pathways.红景天苷通过mTOR和PI3K/Akt信号通路抑制黑色素合成及黑色素瘤生长。
Front Oncol. 2025 Jul 10;15:1583580. doi: 10.3389/fonc.2025.1583580. eCollection 2025.
2
Neutrophil/monocyte-targeted dual-ligands modified liposomes delivering puerarin for ischemia stroke treatment.靶向中性粒细胞/单核细胞的双配体修饰脂质体递送葛根素用于缺血性中风治疗
Mater Today Bio. 2025 Jul 12;33:102077. doi: 10.1016/j.mtbio.2025.102077. eCollection 2025 Aug.
3
Puerarin Improves Cancer-Induced Bone Pain by Recovering Mitochondrial Dysfunction in the Spinal Cord.

本文引用的文献

1
Screening and Identification of Antidepressant Active Ingredients from Extract and Study on Its Mechanism.从提取物中筛选和鉴定抗抑郁活性成分及其作用机制的研究。
Oxid Med Cell Longev. 2021 Sep 9;2021:2230195. doi: 10.1155/2021/2230195. eCollection 2021.
2
[Mechanism of puerarin reversing SH-SY5Y cell injury induced by Aβ_(1-42) based on proteomics].基于蛋白质组学探讨葛根素逆转Aβ_(1-42)诱导的SH-SY5Y细胞损伤的机制
Zhongguo Zhong Yao Za Zhi. 2021 Jul;46(14):3650-3659. doi: 10.19540/j.cnki.cjcmm.20210201.403.
3
Glial Cells as Therapeutic Approaches in Brain Ischemia-Reperfusion Injury.
葛根素通过恢复脊髓线粒体功能障碍改善癌症诱导的骨痛。
J Neuroimmune Pharmacol. 2025 Jun 10;20(1):67. doi: 10.1007/s11481-025-10224-3.
4
Puerarin improves the comorbidity of chronic pain and depression by binding with Bax and reducing mitochondrial dysfunction.葛根素通过与Bax结合并减少线粒体功能障碍来改善慢性疼痛和抑郁症的共病情况。
Mol Pain. 2025 Jan-Dec;21:17448069251335230. doi: 10.1177/17448069251335230. Epub 2025 Apr 4.
5
The isoflavone puerarin promotes generation of human iPSC-derived pre-oligodendrocytes and enhances endogenous remyelination in rodent models.异黄酮葛根素可促进人诱导多能干细胞衍生的少突胶质前体细胞的生成,并增强啮齿动物模型中的内源性髓鞘再生。
J Neurochem. 2025 Jan;169(1):e16245. doi: 10.1111/jnc.16245. Epub 2024 Oct 18.
6
Puerarin attenuates myocardial ischemic injury and endoplasmic reticulum stress by upregulating the Mzb1 signal pathway.葛根素通过上调Mzb1信号通路减轻心肌缺血损伤和内质网应激。
Front Pharmacol. 2024 Aug 13;15:1442831. doi: 10.3389/fphar.2024.1442831. eCollection 2024.
7
Puerarin Alleviates Blood Pressure via Inhibition of ROS/TLR4/NLRP3 Inflammasome Signaling Pathway in the Hypothalamic Paraventricular Nucleus of Salt-Induced Prehypertensive Rats.葛根素通过抑制盐诱导的高血压前期大鼠下丘脑室旁核中的 ROS/TLR4/NLRP3 炎性体信号通路来降低血压。
Nutrients. 2024 Aug 6;16(16):2580. doi: 10.3390/nu16162580.
8
Puerarin alleviates oxaliplatin-induced neuropathic pain by promoting Nrf2/GPX4-mediated antioxidative response.葛根素通过促进 Nrf2/GPX4 介导的抗氧化反应缓解奥沙利铂诱导的神经病理性疼痛。
PLoS One. 2024 Aug 14;19(8):e0308872. doi: 10.1371/journal.pone.0308872. eCollection 2024.
9
Exploring the transformative impact of traditional Chinese medicine on depression: Insights from animal models.探索中医对抑郁症的变革性影响:来自动物模型的见解
World J Psychiatry. 2024 May 19;14(5):607-623. doi: 10.5498/wjp.v14.i5.607.
10
Progress in the Treatment of Central Nervous System Diseases Based on Nanosized Traditional Chinese Medicine.基于纳米中药的中枢神经系统疾病治疗进展
Adv Sci (Weinh). 2024 Apr;11(16):e2308677. doi: 10.1002/advs.202308677. Epub 2024 Feb 28.
胶质细胞作为脑缺血再灌注损伤的治疗方法。
Cells. 2021 Jun 30;10(7):1639. doi: 10.3390/cells10071639.
4
Illuminating Neural Circuits in Alzheimer's Disease.阿尔茨海默病中的神经回路研究
Neurosci Bull. 2021 Aug;37(8):1203-1217. doi: 10.1007/s12264-021-00716-6. Epub 2021 Jun 5.
5
Puerarin ameliorates depression-like behaviors of with chronic unpredictable mild stress mice by remodeling their gut microbiota.葛根素通过重塑慢性不可预测轻度应激小鼠的肠道微生物群来改善其抑郁样行为。
J Affect Disord. 2021 Jul 1;290:353-363. doi: 10.1016/j.jad.2021.04.037. Epub 2021 Apr 27.
6
Glycolytic Metabolism, Brain Resilience, and Alzheimer's Disease.糖酵解代谢、脑弹性与阿尔茨海默病
Front Neurosci. 2021 Apr 28;15:662242. doi: 10.3389/fnins.2021.662242. eCollection 2021.
7
Potential of Pueraria tuberosa (Willd.) DC. to rescue cognitive decline associated with BACE1 protein of Alzheimer's disease on Drosophila model: An integrated molecular modeling and in vivo approach.野葛(Willd.)DC. 对阿尔茨海默病 BACE1 蛋白相关认知能力下降的挽救潜力:一种整合的分子建模和体内方法。
Int J Biol Macromol. 2021 May 15;179:586-600. doi: 10.1016/j.ijbiomac.2021.03.032. Epub 2021 Mar 9.
8
-determined compound from the root of alleviates synaptic plasticity injury induced by Alzheimer's disease the p38MAPK-CREB signaling pathway.从当归根中分离得到的化合物可减轻阿尔茨海默病引起的突触可塑性损伤,其作用机制与 p38MAPK-CREB 信号通路有关。
Food Funct. 2021 Feb 15;12(3):1039-1050. doi: 10.1039/d0fo02388d.
9
Microglial metabolic disturbances and neuroinflammation in cerebral infarction.脑梗死中微胶质细胞的代谢紊乱与神经炎症
J Pharmacol Sci. 2021 Jan;145(1):130-139. doi: 10.1016/j.jphs.2020.11.007. Epub 2020 Nov 21.
10
The gut microbiota in anxiety and depression - A systematic review.焦虑和抑郁中的肠道微生物群——一项系统综述。
Clin Psychol Rev. 2021 Feb;83:101943. doi: 10.1016/j.cpr.2020.101943. Epub 2020 Oct 29.